| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc (BCRX) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. BCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.32M | $12.32M | - | |
| Pres | 902.6K | $8.39M | - | |
| Other | 398.8K | $3.71M | - | |
| CFO | 268.7K | $2.50M | - | |
| Dir | 93.2K | $866.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 | Milano Vincent | Director | Buy | 7,500 | $12.19 | $91,425.00 | +75.0% | +42.0% | -1.8% | |
| Nov 23, 2021 | Doyle Anthony70 | Chief Financial Officer | Buy | 35,258 | $12.48 | $440,019.84 | +60.3% | +43.5% | +0.2% | |
| Nov 15, 2021 | Abercrombie George B68 | Director | Sale+OE | 5,000 | $12.27 | $61,350.00 | -100% | +50.0% | +11.5% | |
| Oct 15, 2021 | Hutson Nancy J58 | Director | Sale+OE | 105,000 | $15.40 | $1,617,000.00 | -61.7% | +6.7% | -10.6% | |
| Sep 15, 2021 | Abercrombie George B68 | Director | Sale+OE | 5,000 | $15.06 | $75,300.00 | -100% | -24.2% | -14.9% | |
| Sep 13, 2021 | Lee Kenneth B Jr | Director | Sale+OE | 6,000 | $15.35 | $92,100.00 | -19.8% | -25.2% | -15.0% | |
| Sep 10, 2021 | Abercrombie George B68 | Director | Sale+OE | 74,000 | $15.09 | $1,116,660.00 | -100% | -22.5% | -11.5% | |
| Jul 15, 2021 | Abercrombie George B68 | Director | Sale+OE | 5,000 | $15.69 | $78,450.00 | -62.5% | -5.1% | -26.3% | |
| Jun 10, 2021 | Hutson Nancy J58 | Director | Sale+OE | 23,333 | $16.86 | $393,394.38 | -26.4% | -13.1% | -42.7% | |
| May 28, 2021 | Sheridan William P67 | Chief Medical Officer | Sale+OE | 163,573 | $15.01 | $2,455,431.28 | -85.0% | -2.7% | -38.1% |